查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2003960

乳胶医用手套市场：2026-2032年全球市场预测（依产品涂层、应用、最终用户和销售管道划分）

Latex Medical Gloves Market by Product Coating, Application Type, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年乳胶医用手套市值为141.3亿美元，预计到2026年将成长至149.3亿美元，复合年增长率为5.24%，到2032年将达到202.2亿美元。

主要市场统计数据
基准年 2025 141.3亿美元
预计年份：2026年 149.3亿美元
预测年份 2032 202.2亿美元
复合年增长率 (%) 5.24%

对乳胶医用手套品类的深入介绍，清楚地平衡了临床性能优先事项与供应链和监管现实。

乳胶医用手套在临床表现、供应链复杂性和不断变化的监管要求之间处于关键的交汇点。本报告首先将乳胶手套置于临床对触觉灵敏度和贴合度的需求背景下进行分析，同时对比分析了乳胶蛋白致敏性日益增长的担忧以及整个行业向替代弹性体转变的趋势。报告首先阐明了产品范围，包括无粉和有粉产品，并区分了优先考虑灵巧性、阻隔功能或长时间佩戴的应用场景。

临床安全问题、永续性要求和不断变化的分销管道如何相互交织，从根本上改变乳胶手套产业的格局。

乳胶医用手套产业正经历一场变革，其驱动力包括安全通讯协定的完善、材料科学的进步以及医疗采购结构的变化。在临床环境中，人们对乳胶过敏的认识不断提高，加速了许多医疗机构采用替代材料，迫使製造商改进配方并调整生产策略。同时，永续性要求正在重塑产品设计和包装决策，而生命週期考量也影响采购选择，因为医院和医疗系统都在努力减少医疗废弃物并提高环境资讯揭露水平。

分析研究计画于 2025 年实施的美国关税变化将如何累积改变整个乳胶手套价值链的成本结构、筹资策略和供应弹性。

美国宣布的2025年关税调整可能对乳胶医用手套的采购、定价和库存策略产生累积压力。关税对进口医疗用品最直接的影响是增加依赖进口的买家的收货成本。因此，采购团队将被迫重新评估其供应商组合，并将采购量转向国内生产或其他替代来源。从长远来看，这些成本讯号将促使企业做出结构性调整。供应商可能会重组製造地、投资本地或区域生产，或重新谈判贸易条款以维持市场进入。

将产品涂层、应用、终端用户趋势和分销管道与临床要求和采购行为联繫起来的详细细分洞察。

细分市场分析揭示了微妙的需求模式，这些模式应指南整个乳胶手套品类的产品开发和商业策略。根据产品涂层，临床医生和采购负责人会根据易用性、颗粒控制和监管认可的差异来区分无粉手套和有粉手套。在污染控制和患者安全至关重要的环境中，无粉产品越来越受欢迎，而有粉产品在需要快速佩戴的特定应用领域仍然效用。依应用领域划分，市场分为检查手套和外科手套，外科手套又进一步细分为心血管外科、一般外科和整形外科。每个领域对触感、拉伸强度和无菌性都有其独特的要求，指南材料的选择和品质检验。

美洲、欧洲、中东和非洲以及亚太地区的区域法规结构、製造地和采购重点如何影响产品采用和供应弹性？

区域趋势影响整个乳胶手套品类的供应能力和需求偏好，美洲、欧洲、中东、非洲和亚太地区之间存在显着差异。在美洲，临床采购负责人除了重视物流可靠性外，还优先考虑合规性和供应商透明度。此外，本地生产能力和近岸外包方案也越来越受到重视，以降低进口中断和关税波动带来的风险。从临床需求角度来看，北美和南美的医疗机构通常优先考虑兼具良好触感和成熟品管系统的产品。

製造商、经销商和策略伙伴如何透过品质系统、供应合约和附加价值服务来脱颖而出，从而与机构建立长期合作关係？

乳胶手套产业的竞争格局正因能力差异化、品质保证投入和策略伙伴关係而重塑。领先的製造商正投资于製程控制、过敏原减少技术和第三方认证，以维繫与医院和手术室的合作关係。同时，新参与企业则专注于生物降解材料、客製化无菌包装和快速反应生产线等细分价值提案，以支持紧急采购。分销合作伙伴和医疗批发商正在其服务组合中增加库存分析、合约管理支援和电子采购整合等服务，从而提升了数位化管道和数据驱动型客户参与的重要性。

製造商和经销商现在可以实施的可操作策略行动，以增强韧性、满足临床需求并实现永续的商业性差异化。

产业领导企业可以透过调整产品系列、供应链和经营模式，使其与不断变化的临床和监管要求相适应，从而采取果断措施来巩固其市场地位。首先，製造商应优先投资于减少过敏原的製程、完善的品管系统以及符合医院采购要求的可验证检验，从而减少供应商认证过程中的阻力。其次，企业应实现製造地多元化，并确保关键供应地点的冗余，以避免关税风险和物流中断的影响，同时也能快速回应区域性需求激增。

为了检验可操作的产业见解，调查方法，结合了对临床负责人的访谈、供应链映射和情境分析。

本报告的调查方法结合了定性和定量方法，旨在全面了解乳胶医用手套对环境的影响。首先，我们对临床采购经理、感染控制专家、分销主管和监管顾问进行了访谈，以了解他们对产品性能、采购限制和认证障碍的第一手观点。其次，我们利用监管指导文件、生产最佳实践框架和公开的公司报告进行二次研究，全面检验了有关生产方法、品质系统和分销模式的说法。

综合结论强调，品质、供应弹性和永续性是决定乳胶手套长期竞争优势的必要条件。

总而言之，乳胶医用手套正处于策略转折点，临床安全考量、供应链韧性和永续性需求在此交汇融合。儘管乳胶在许多临床应用中，尤其是在灵敏度和贴合度至关重要的外科手术中，仍然具有明显的触感优势，但过敏问题和替代弹性体的兴起正在重塑采购决策和创新重点。同时，随着买家要求更高的透明度、更快的补货速度和更柔软性的合约条款以规避成本和供应波动风险，分销管道和合约机制也在不断演变。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：乳胶医用手套市场（依产品涂层划分）

  • 无粉
  • 粉末

第九章：按应用分類的乳胶医用手套市场

  • 咨询
  • 外科手术
    • 心血管外科
    • 一般外科
    • 整形外科手术

第十章：乳胶医用手套市场：依最终用户划分

  • 门诊部
  • 诊断检查室
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院

第十一章：乳胶医用手套市场：依销售管道划分

  • 在线的
  • 离线

第十二章：乳胶医用手套市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：乳胶医用手套市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：乳胶医用手套市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国乳胶医用手套市场

第十六章：中国乳胶医用手套市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ansell Limited
  • Cardinal Health Inc
  • Clean Q Grip（M）Sdn. Bhd.
  • Dynarex Corporation
  • Hartalega Holdings Berhad
  • Kimberly-Clark Corporation
  • Kossan Rubber Industries Bhd
  • Medline Industries LP
  • Semperit AG Holding
  • SHIELD Scientific BV
  • Supermax Corporation Berhad
  • Top Glove Corporation Bhd
  • UG Healthcare Corporation
  • Valutek Inc.
Product Code: MRR-2D668742FE43

The Latex Medical Gloves Market was valued at USD 14.13 billion in 2025 and is projected to grow to USD 14.93 billion in 2026, with a CAGR of 5.24%, reaching USD 20.22 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.13 billion
Estimated Year [2026] USD 14.93 billion
Forecast Year [2032] USD 20.22 billion
CAGR (%) 5.24%

A clear, contextual introduction to the latex medical gloves category that balances clinical performance priorities with supply chain and regulatory realities

Latex medical gloves occupy a critical intersection of clinical performance, supply chain complexity, and evolving regulatory expectations. This report's introduction frames the latex glove category in the context of clinical demands for tactile sensitivity and fit, juxtaposed against growing concerns about latex protein sensitization and the broad industry transition toward alternative elastomers. The narrative begins by clarifying the product family, including powder-free and powdered options, and distinguishes between use cases that prioritize dexterity, barrier integrity, or extended wear.

The introductory analysis then maps stakeholder priorities across hospital procurement teams, ambulatory care facilities, diagnostic laboratories, and home healthcare providers, explaining how procurement drivers differ by care setting. It emphasizes the distinct requirements of examination gloves versus surgical gloves, noting how surgical sub-specialties such as cardiovascular, general, and orthopedic surgery exert day-to-day and procedural performance demands that influence product selection. Finally, the introduction outlines the key forces shaping category dynamics today: patient safety and allergy mitigation, sustainability and waste management pressures, regulatory scrutiny over manufacturing practices, and the competitive interplay among manufacturers, distributors, and e-commerce platforms. These foundational observations set up the deeper, data-driven inquiries that follow, providing context for segmentation, regional dynamics, and strategic recommendations.

How clinical safety concerns, sustainability mandates, and evolving distribution channels are converging to fundamentally reshape the latex glove industry landscape

The landscape for latex medical gloves is undergoing transformative shifts driven by safety protocols, material science evolution, and structural changes in healthcare procurement. At the clinical interface, heightened awareness of latex allergies has accelerated the adoption of alternative materials in many institutions, prompting manufacturers to refine formulations and change production emphasis. Concurrently, sustainability imperatives are reshaping product design and packaging decisions, with lifecycle considerations influencing procurement choices as hospitals and health systems seek to reduce medical waste and improve environmental disclosures.

On the commercial side, distribution models are evolving. Traditional direct tenders, both government and private, continue to command significant volumes, yet e-commerce channels including manufacturer websites and third-party platforms are enabling faster replenishment cycles and expanded vendor visibility. Third-party distribution through medical distributors and pharmacy channels remains vital for last-mile delivery and catalog consolidation. These shifts are reinforced by technological adoption in sterilization, quality testing, and traceability, which together elevate supplier qualification standards. As a result, contract dynamics are changing: longer qualification timelines and enhanced compliance documentation are becoming prerequisites for supply continuity. This section synthesizes these forces to illustrate how clinical, environmental, and logistical drivers are converging to redefine competitive advantage in the latex glove market.

An analytical examination of how United States tariff changes scheduled for 2025 can cumulatively alter cost structures, sourcing strategies, and supply resilience across the latex glove value chain

Anticipated tariff adjustments announced for 2025 by the United States have the potential to exert cumulative pressure across sourcing, pricing, and inventory strategies for latex medical gloves. When tariffs are applied to imported medical supplies, the most immediate effect manifests in landed cost increases for import-dependent buyers, which in turn incentivizes procurement teams to reassess supplier portfolios and shift volumes toward domestic production or alternative sourcing jurisdictions. Over time, these cost signals catalyze structural responses: suppliers may reconfigure manufacturing footprints, invest in local or regional production, or renegotiate commercial terms to preserve market access.

Beyond direct cost implications, tariff-driven shifts influence supply chain behavior. Buyers commonly respond by increasing safety stock, diversifying supplier lists, and accelerating qualification for secondary vendors to mitigate single-source exposure. Manufacturers and distributors facing tariff-related margin compression often pursue operational efficiencies, such as higher automation levels or streamlined product SKUs, to offset input cost rises. In parallel, payers and health systems evaluate clinical equivalency among glove types; where latex alternatives meet clinical needs and regulatory requirements, substitution may reduce reliance on tariff-affected imports. The cumulative impact of tariffs is therefore multifaceted: it alters cost structures, accelerates supply chain diversification, prompts regional production investment, and strengthens the commercial case for material substitution and procurement flexibility.

In-depth segmentation insights that connect product coating, application, end-user dynamics, and distribution channels to clinical requirements and procurement behavior

Segmentation analysis reveals nuanced demand patterns that should inform product development and commercial strategies across the latex glove category. Based on product coating, clinicians and procurement officers distinguish between powder-free and powdered gloves due to differences in donning ease, particulate control, and regulatory acceptability; powder-free options are increasingly preferred in settings where contamination control and patient safety are paramount, while powdered variants retain niche utility where rapid donning is critical. Based on application type, the market is studied across examination gloves and surgical gloves, with the surgical subset further categorized into cardiovascular surgery, general surgery, and orthopedic surgery, each of which imposes distinct tactile, tensile, and sterility requirements that inform material selection and quality validation.

Based on end user, demand streams vary significantly: ambulatory care centers prioritize cost-effectiveness and supply consistency; diagnostic laboratories emphasize chemical resistance and contamination control; home healthcare requires packaging and dispensing formats conducive to non-clinical caregivers; and hospitals, which are further segmented into private and public institutions, balance performance with procurement constraints and regulatory compliance. Finally, based on distribution channel, procurement pathways include direct tender, e-commerce, and third-party distribution. Direct tender activity, encompassing both government and private tenders, remains a dominant procurement mechanism for institutional buyers, while e-commerce - via manufacturer websites and third-party platforms - accelerates replenishment and expands buyer choice. Third-party distribution, including medical distributors and pharmacy stores, continues to serve critical roles in inventory aggregation, clinical supply consulting, and last-mile logistics. Understanding the intersections among these segmentation axes is essential to align product portfolios, regulatory dossiers, and commercial approaches with buyer expectations and procedural demands.

How regional regulatory frameworks, manufacturing footprints, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape product adoption and supply resilience

Regional dynamics shape both supply-side capabilities and demand-side preferences across the latex glove category, with pronounced variation between the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinical buyers emphasize regulatory compliance and supplier transparency alongside logistical reliability; regional manufacturing capacity and nearshoring options are increasingly evaluated to reduce exposure to import disruptions and tariff volatility. Transitioning from clinical needs to procurement realities, facilities in North and South America frequently prioritize products that combine tactile performance with demonstrable quality management systems.

In Europe Middle East & Africa, regulatory rigor and sustainability expectations are often elevated, prompting manufacturers and distributors to focus on allergen reduction strategies, product stewardship, and extended supply-chain traceability. Procurement teams in these regions also consider life-cycle impacts and waste management policies when evaluating glove options. In the Asia-Pacific region, proximity to large-scale manufacturing hubs shapes competitive dynamics, delivering cost advantages but also heightening attention to labor standards and environmental controls. Across all regions, inter-regional trade flows, logistics infrastructure, and regulatory alignment influence the pace of new product adoption and the strategic positioning of suppliers. Collectively, these regional dynamics inform decisions on production siting, compliance investments, and go-to-market prioritization.

How manufacturers, distributors, and strategic partners are differentiating through quality systems, supply agreements, and value-added services to secure long-term institutional relationships

Competitive behavior among firms operating in the latex glove category is being redefined by capability differentiation, quality assurance investments, and strategic partnerships. Leading manufacturers are investing in process controls, allergen mitigation technologies, and third-party certifications to sustain hospital and surgical relationships, while new entrants focus on niche value propositions such as biodegradable materials, bespoke sterile packaging, or rapid-response production lines that support emergency procurement. Distribution partners and medical wholesalers are expanding service portfolios to include inventory analytics, contract management support, and e-procurement integration, thereby increasing the importance of digital channels and data-driven customer engagement.

Strategic alliances between manufacturers and healthcare systems are increasingly prevalent, with long-term supply agreements conditioned on compliance milestones and volume flexibility. Contract manufacturers and private-label producers are also playing a larger role, allowing health systems and group purchasing organizations to secure branded-equivalent products under private contracts. Additionally, mergers and acquisitions remain a tool for acquiring manufacturing scale, technological capabilities, and access to new geographies, while forward-looking players emphasize ESG reporting and occupational safety as differentiators. Taken together, company strategies now encompass operational resilience, regulatory readiness, and customer-centric services as core competitive axes in the latex glove ecosystem.

Practical strategic actions manufacturers and distributors can implement now to build resilience, meet clinical demands, and create sustainable commercial differentiation

Industry leaders can take decisive actions to strengthen market positions by aligning product portfolios, supply chains, and commercial models with evolving clinical and regulatory expectations. First, manufacturers should prioritize investments in allergen reduction processes, robust quality management systems, and verifiable certifications that address hospital procurement requirements, thereby reducing friction during supplier qualification. Second, organizations should diversify manufacturing footprints and add redundancy in critical supply nodes to guard against tariff exposure and logistic disruptions, while enabling faster response to region-specific demand spikes.

Third, companies should expand digital engagement capabilities across e-commerce platforms and procurement integrations to improve order visibility, reduce lead times, and support just-in-time replenishment models. Fourth, building collaborative partnerships with distributors and health systems to co-develop packaging formats, sterile supply kits, and education for end users can strengthen customer loyalty and justify premium positioning. Fifth, embed sustainability into product design and end-of-life planning, including exploring biodegradable compounds and recyclable packaging, to meet institutional environmental targets. Finally, procurement and commercial teams should develop scenario-based contracting approaches that incorporate flexibility clauses for tariff events, quality incidents, and rapid scale-up requests. These combined actions will improve resilience, support clinical acceptance, and create commercial differentiation in a competitive and regulated landscape.

A rigorous, mixed-methods research methodology that integrates frontline clinical interviews, supply-chain mapping, and scenario analysis to validate actionable industry insights

The research methodology underpinning this report blends qualitative and quantitative techniques to generate a comprehensive view of the latex medical gloves environment. Primary interviews were conducted with clinical procurement leads, infection control specialists, distribution executives, and regulatory advisors to capture first-hand perspectives on product performance, sourcing constraints, and qualification hurdles. Secondary research drew on regulatory guidance documents, manufacturing best-practice frameworks, and publicly disclosed company reports to triangulate claims about production methods, quality systems, and distribution models.

Analytical methods included supply-chain mapping to identify critical nodes and points of vulnerability, procurement pathway analysis to compare direct tender, e-commerce, and third-party distribution impacts, and product-segmentation alignment studies that connect clinical applications to material and design attributes. Scenario analysis was used to explore the implications of tariff shifts, regulatory tightening, and substitution trends without making market size or forecasting claims. Throughout, validation steps ensured that insights reflect operational realities and are consistent with documented regulatory expectations and clinical practice. The methodology balances practitioner testimony with documentary evidence to provide actionable intelligence for decision-makers.

An integrative conclusion emphasizing the need for quality, supply resilience, and sustainability to determine long-term competitive advantage in latex gloves

In conclusion, the latex medical gloves category stands at a strategic inflection point where clinical safety considerations, supply chain resilience, and sustainability imperatives intersect. Latex continues to offer distinct tactile advantages for many clinical applications, especially in surgical specialties that demand sensitivity and fit, yet allergy concerns and the rise of alternative elastomers are reshaping procurement decisions and innovation agendas. Distribution channels and contracting mechanisms are simultaneously evolving as buyers seek greater transparency, faster replenishment, and contractual flexibility to hedge against cost and availability shocks.

To navigate this evolving landscape, stakeholders must balance near-term operational continuity with mid-term strategic investments in quality systems, regional manufacturing capabilities, and product stewardship. Procurement teams and suppliers who align their offerings with clinical requirements, regulatory expectations, and environmental commitments will be best positioned to secure long-term institutional relationships. The combination of targeted product development, diversified sourcing strategies, and collaborative commercial models will determine which organizations emerge as reliable partners to healthcare systems operating under increasingly stringent performance and sustainability standards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Latex Medical Gloves Market, by Product Coating

  • 8.1. Powder-Free
  • 8.2. Powdered

9. Latex Medical Gloves Market, by Application Type

  • 9.1. Examination
  • 9.2. Surgical
    • 9.2.1. Cardiovascular Surgery
    • 9.2.2. General Surgery
    • 9.2.3. Orthopedic Surgery

10. Latex Medical Gloves Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Laboratories
  • 10.3. Home Healthcare
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals

11. Latex Medical Gloves Market, by Sales Channel

  • 11.1. Online
  • 11.2. Offline

12. Latex Medical Gloves Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Latex Medical Gloves Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Latex Medical Gloves Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Latex Medical Gloves Market

16. China Latex Medical Gloves Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Ansell Limited
  • 17.6. Cardinal Health Inc
  • 17.7. Clean Q Grip (M) Sdn. Bhd.
  • 17.8. Dynarex Corporation
  • 17.9. Hartalega Holdings Berhad
  • 17.10. Kimberly-Clark Corporation
  • 17.11. Kossan Rubber Industries Bhd
  • 17.12. Medline Industries LP
  • 17.13. Semperit AG Holding
  • 17.14. SHIELD Scientific B.V.
  • 17.15. Supermax Corporation Berhad
  • 17.16. Top Glove Corporation Bhd
  • 17.17. UG Healthcare Corporation
  • 17.18. Valutek Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LATEX MEDICAL GLOVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LATEX MEDICAL GLOVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDER-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY POWDERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY EXAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 120. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 122. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. GCC LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 141. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 143. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. G7 LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 148. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 150. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. NATO LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL LATEX MEDICAL GLOVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA LATEX MEDICAL GLOVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY PRODUCT COATING, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY APPLICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA LATEX MEDICAL GLOVES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)